Holger Moch, MD is Professor of Pathology at the University Zurich and Chairman of the Institute for Pathology and Molecular Pathology, University Hospital Zurich, Switzerland since 2004. Holger Moch is board certified in Pathology and in Molecular Pathology. He graduated from Humboldt University Berlin (Charité), Germany and received his MD in 1988. Following graduation, he was a resident at the Institute for Pathology, Charité Berlin and at the Institute for Pathology, University Basel, Switzerland. He was a research fellow in the Division of Molecular Cytometry, Department of Laboratory Medicine, University of California San Francisco; USA and a visiting fellow at Harvard Medical School, Department of Pathology, Massachusetts General Hospital Boston, Massachusetts, USA. In 2001, he was promoted to Associate Professor of Pathology (Titularprofessor) of the University Basel, Switzerland.
Dr. Moch developed a robust translational research program to understand the molecular background of urogenital tumors. In 2014, he has founded the joint Competence Center for Personalized Medicine (CC-PM) at the University Zurich and the Swiss Federal Institute of Technology in Zurich (ETHZ) and serves as CC-PM Co-Director. His work is described in more than 500 peer-reviewed papers (H-Index 77) and he edited the 2016 WHO “blue book” World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs. He is a member of the German National Academy of Science Leopoldina and the Swiss Academy of Medical Sciences. Holger Moch is president-elect of the European Society of Pathology (ESP).